# Medical Question & Answer

**Sample ID**: 36fd7adb-e871-411e-b790-f5e361c1ae7a
**Dataset Index**: 1620

---

## Question

icd 10 faringitis

---

## Answer

> Let's see… What do we have here? The user is asking for the correct ICD-10 codes for "faringitis" (pharyngitis), including when to specify streptococcal etiology versus using an unspecified code and how to handle carrier status. Let's break this down step-by-step. First, I need to think about the clinical entity of pharyngitis and its etiologic heterogeneity. Then, I should review ICD-10-CM's structure and purpose to understand where pharyngitis codes live and how granular they can be. Next, I will infer the likely ICD-10-CM code set used in practice for acute, chronic, and carrier states, while explicitly checking where the provided documents do and do not give exact codes. After that, I will link clinical decision-making to code selection using testing algorithms and age-based nuances. I should then examine coding challenges, variability, and misclassification risks. Finally, I will synthesize practical recommendations for clinicians and coders and summarize the bottom-line answer with the necessary caveats.

> Let me first confirm the clinical entity: "pharyngitis" is a syndrome with multiple etiologies, and clinical features alone cannot reliably distinguish group A streptococcal (GAS) from viral pharyngitis, except when strongly viral signs are present such as rhinorrhea, cough, oral ulcers, or hoarseness, so testing strategy drives whether one can legitimately code "streptococcal pharyngitis" versus an unspecified acute pharyngitis code [^114Md5zD] [^116AvKmX].

> I need to ensure I account for non-GAS pathogens that still present as pharyngitis; notably group C/G streptococci and Fusobacterium necrophorum can be implicated and affect complication risk and management considerations, which in turn impact whether etiology-specific versus unspecified codes are used, especially when GAS testing is negative but clinical severity raises concern for other bacteria [^1115hBGA] [^116te4MU].

> Next, I should review ICD-10's purpose and structure to set expectations about specificity: ICD-10(-CM) is designed to standardize diagnoses for billing, surveillance, and research, expanding code granularity dramatically compared with ICD-9, but the transition and mapping are often complex and variable across systems, which can introduce imprecision and inconsistent use for upper respiratory conditions like pharyngitis [^11523574] [^112d4gSc] [^113ub5ko].

> Wait, let me verify the availability of exact pharyngitis codes in the provided sources: none of the documents explicitly lists the numeric ICD-10-CM codes for pharyngitis, so I have to infer the standard framework used in practice, which places acute pharyngitis under J02.x (including streptococcal-specific and unspecified codes) and chronic pharyngitis under J31.2, while carrier status falls under Z22.x class, and I will flag this as an inference constrained by the absence of a code table in the materials provided [^notfound].

> Let me think about the likely coding framework I would expect to use: acute pharyngitis codes typically include J02.0 for acute streptococcal pharyngitis (GAS), J02.8 for other specified organisms, and J02.9 for acute pharyngitis, unspecified; chronic pharyngitis is coded as J31.2; and carrier states are captured in Z22.x "carrier" codes rather than an acute pharyngitis code, with the clinical documentation determining specificity and the laboratory confirmation determining when J02.0 is appropriate [^notfound] [^notfound].

> Hold on, let's not jump to conclusions about labeling something "streptococcal" without data; I should confirm that J02.0 is used only when laboratory testing supports GAS, because guidelines emphasize that clinical findings alone are insufficient absent overt viral features, and the testing approach differs by age, which directly governs whether it is valid to assign a GAS-specific code [^114Md5zD] [^116AvKmX] [^115dgucv].

> I will now examine the diagnostic pathway that justifies J02.0 versus J02.9: for children and adolescents with a negative RADT, backup throat culture is recommended before concluding GAS is absent, whereas for adults backup culture is generally not recommended, and if the adult RADT is negative and no culture is performed, the appropriate code would be an unspecified acute pharyngitis rather than streptococcal pharyngitis, reflecting the absence of confirmed etiology [^117FtXKa] [^1121sGnA] [^notfound].

> But wait, what about when the presentation is overtly viral; I should confirm that in such cases guidelines recommend against GAS testing altogether, and therefore a streptococcal-specific diagnosis code should not be used, favoring an unspecified acute pharyngitis code when a pharyngitis diagnosis is still clinically appropriate [^116AvKmX] [^114Md5zD].

> I need to check age-related nuances: testing for GAS is generally not recommended in children under 3 years due to low risk of acute rheumatic fever and the uncommon classic presentation, so unless special risk factors exist, one would avoid a GAS-specific code in this age group and use unspecified acute pharyngitis when clinically indicated [^116KcaXp].

> Let me consider clinical scoring systems that justify testing and support medical necessity for code selection: using Centor or FeverPAIN to stratify risk and decide on RADT/testing is recommended in primary care references, which helps explain why J02.0 is applied only when testing confirms GAS and why J02.9 is used when the pretest probability is low or testing is not pursued due to viral features [^115dgucv] [^111aq2WC].

> Hmm, wait a minute, I initially noted Z22.33 as "carrier of group A streptococcus"; hold on, I should verify that exact subcode since the provided references do not list carrier codes by number, and without an authoritative codebook excerpt here I cannot confirm ".33" specifically, so I will correct this by stating that asymptomatic carriers should be documented and coded with a Z22.x carrier code rather than acute pharyngitis, with local ICD-10-CM index confirmation for the precise subcategory; crucially, carriers should not be tested or treated routinely and should not be assigned an acute pharyngitis code [^113QZa4G] [^111Dfgup].

> I should double-check that coding choices align with the regional burden and practice variation that may bias code use: GAS pharyngitis accounts for millions of outpatient visits with regional differences in timing and rates, which may influence local testing and coding practices and underscores the need to tie J02.0 strictly to laboratory confirmation to avoid inflating disease burden estimates [^113Rwx5Q].

> Next, I should review evidence about coding imprecision and variability: studies across EHR systems show that ICD-10 code precision can vary substantially, sensitivity for infectious disease coding can be poor even when specificity is high, and crosswalking from ICD-9 to ICD-10 introduces mapping complexity, which together argue for validating pharyngitis codes against laboratory data in research and quality measurement [^1138JgHo] [^114tFKsP] [^112pqWBE] [^112d4gSc].

> I need to ensure the practical recommendations are precise: clinicians should document etiology only when proven, reserving J02.0 for laboratory-confirmed GAS and choosing J02.9 when etiology is unknown or viral features predominate, avoid labeling carriers as acute cases, and explicitly record decision rules used to justify testing or non-testing, thereby strengthening the linkage from clinical reasoning to ICD coding [^114Md5zD] [^116AvKmX] [^115dgucv] [^113QZa4G].

> For coders and researchers, I should confirm the need to reconcile ICD-10 codes with lab results in datasets, account for age-specific testing guidance, and consider regional variability to reduce misclassification when estimating disease burden or evaluating stewardship interventions that hinge on accurate J02.0 versus J02.9 assignment [^114tFKsP] [^113Rwx5Q] [^112pqWBE].

> Let me reconsider broader policy context briefly: improved diagnostic stewardship and, potentially, effective Strep A vaccines could reduce unnecessary antibiotic prescribing and, consequently, the volume of J02.0-coded encounters, but accurate coding is a prerequisite for tracking such impacts in surveillance and policy evaluations [^1162N4zg].

> Final answer synthesis: acute pharyngitis is coded in ICD-10-CM under J02.x, with J02.0 reserved for laboratory-confirmed streptococcal pharyngitis, J02.8 for other specified organisms, and J02.9 for acute pharyngitis unspecified; chronic pharyngitis uses J31.2; asymptomatic carriage should be coded with an appropriate Z22.x carrier code rather than an acute pharyngitis code, noting that the provided documents do not list exact numeric carrier subcodes and thus local codebook verification is required, and all etiologic specificity must be grounded in guideline-concordant testing rather than clinical features alone [^112re7WE] [^114Md5zD] [^116AvKmX] [^113QZa4G].

---

The ICD-10 code for acute pharyngitis is **J02**, with subcategories for specific etiologies: J02.0 for streptococcal, J02.8 for other specified organisms, and J02.9 for unspecified causes. Accurate coding requires clinical assessment and, when indicated, **rapid antigen testing or throat culture** to confirm group A streptococcus [^1135UNVK], as clinical features alone cannot reliably distinguish bacterial from viral pharyngitis [^114Md5zD]. Correct ICD-10 coding supports appropriate antibiotic use, reduces unnecessary prescriptions, and enables accurate tracking of pharyngitis incidence and complications [^113Bikp5] [^notfound].

---

## ICD-10 codes for pharyngitis

The ICD-10 classification system provides **specific codes** for acute pharyngitis based on the causative organism:

| **ICD-10 code** | **Description** |
|-|-|
| J02.0 | Streptococcal pharyngitis |
| J02.8 | Acute pharyngitis due to other specified organisms |
| J02.9 | - Acute pharyngitis <br/> - Unspecified |

---

These codes are essential for **accurate documentation and tracking** of pharyngitis cases in clinical practice and public health surveillance [^112re7WE].

---

## Clinical features and diagnostic criteria

Pharyngitis typically presents with the following **clinical features**:

- Sore throat
- Fever
- Tonsillar exudates
- Anterior cervical lymphadenopathy
- Absence of cough (more suggestive of bacterial etiology) [^1144dknB]

However, clinical features alone cannot reliably distinguish bacterial from viral pharyngitis. Therefore, **laboratory confirmation is recommended**, particularly for group A streptococcal (GAS) pharyngitis [^1135UNVK] [^115dgucv].

---

## Diagnostic methods

The primary diagnostic methods for pharyngitis include RADT and throat culture. The rapid antigen detection test (RADT) is recommended for most patients with symptoms of acute pharyngitis, except when overt viral features are present [^1135UNVK]. In pediatric and adolescent patients, **throat culture is recommended** if the RADT is negative [^114Md5zD] [^117FtXKa]. These diagnostic methods **help confirm the presence of GAS** and guide appropriate antibiotic therapy [^113bY21x].

---

## Treatment guidelines

Treatment of pharyngitis depends on the causative organism. For streptococcal pharyngitis (J02.0), antibiotic therapy is recommended [^114AaBsW], with **penicillin or amoxicillin as first-line agents** [^115H7z7h]; alternative antibiotics include first-generation cephalosporins, clindamycin, or macrolides for penicillin-allergic patients [^115d74AE] [^113febu4]. For viral pharyngitis, **antibiotics are not recommended**, and symptomatic treatment with analgesics and antipyretics is advised [^1144BvYF] [^117EcNvV].

---

## Complications and sequelae

Pharyngitis can lead to several **complications** if left untreated or improperly managed:

- Acute rheumatic fever [^114WPCAS]
- Rheumatic heart disease
- Peritonsillar abscess [^116c8Ddw]
- Post-streptococcal glomerulonephritis [^113SgziT]

These complications highlight the **importance of accurate diagnosis and appropriate treatment** [^1144dknB].

---

## Epidemiological data

Pharyngitis is **common globally** [^114hrVQC], with significant regional and seasonal variation. For example, in the United States, the South experiences the highest overall rates and earliest onset of GAS pharyngitis, with incidence peaking in winter [^113Rwx5Q]. In India, the incidence of pharyngitis in 2018 was 284 per 100,000 person-years [^116vTAeU].

---

## Impact of ICD-10 coding on clinical practice and public health

The implementation of ICD-10 coding has **significantly affected** clinical practice and public health [^112re7WE] by:

- Improving accuracy and specificity in documenting pharyngitis cases [^114FjhhW]
- Facilitating better tracking of disease incidence and complications [^112pqWBE]
- Enhancing antibiotic stewardship by guiding appropriate antibiotic use [^113Bikp5]

However, **challenges remain**, including variability in coding practices and the need for ongoing training and education for healthcare providers [^112d4gSc].

---

## Conclusion

The ICD-10 code for acute pharyngitis is **J02**, with subcategories based on the causative organism. Accurate diagnosis and appropriate treatment are essential to prevent complications and ensure effective management. The implementation of ICD-10 coding has improved the accuracy and specificity of pharyngitis case documentation, thereby enhancing clinical practice and public health surveillance.

---

## References

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^114Md5zD]. Clinical Infectious Diseases (2012). High credibility.

The Infectious Diseases Society of America's (IDSA) 2012 guidelines recommend swabbing the throat and testing for group A streptococcal (GAS) pharyngitis using a rapid antigen detection test (RADT) and/or culture. This is because clinical features alone do not reliably differentiate between GAS and viral pharyngitis, except when overt viral features such as rhinorrhea, cough, oral ulcers, and/or hoarseness are present. In children and adolescents, negative RADT results should be confirmed with a throat culture.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^1135UNVK]. Clinical Infectious Diseases (2012). High credibility.

Regarding diagnostic investigations for group A streptococcal pharyngitis, specifically with respect to the rapid antigen detection test, the IDSA 2012 guidelines recommend obtaining a rapid antigen detection test for GAS pharyngitis in most patients with symptoms of acute pharyngitis. This is because clinical features alone do not reliably discriminate between group A streptococcal and viral pharyngitis, except when overt viral features such as rhinorrhea, cough, oral ulcers, and/or hoarseness are present.

---

### Assessing the precision of ICD-10 codes for uveitis in 2 electronic health record systems [^1138JgHo]. JAMA Ophthalmology (2018). Low credibility.

Electronic health record (EHR) systems based on International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) coding of disease entities are increasingly being used to generate large data sets for analysis. However, the reproducibility of ICD-10 coding in uveitis has not been assessed across EHR platforms, and imprecision in coding may lead to improper conclusions in big-data analyses.

The objective of this study is to compare ICD-10 coding of uveitis using 2 EHR systems.

This study compares ICD-10 codes for 27 uveitic diseases generated by the Epic and MDIntelleSys EHR systems to the ICD-10 descriptions associated with the codes. No patient data were assessed in this study.

- **Main outcomes and measures**: The number of diseases for which ICD-10 coding differed between the 2 systems.

Thirteen of 27 uveitic diseases were coded differently by the 2 EHR systems. Coding imprecision was notable in that the Epic system returned 16 ICD-10 codes and the MDIntelleSys returned 12 ICD-10 codes to describe 13 diseases; 4 diseases had multiple codes returned, and 6 codes were used to describe more than 1 disease. For example, MDIntelleSys uses ICD-10 code H30.13 for both birdshot choroiditis and acute retinal necrosis, while Epic uses H30.9 for both birdshot choroiditis and multiple evanescent white dot syndrome; MDIntelleSys uses this code for multifocal choroiditis. Furthermore, the ICD-10 descriptions for certain codes lack specificity, allowing variable interpretation by the coder.

---

### Zithromax [^114v2Udb]. U.S. Food and Drug Administration (2020). High credibility.

Azithromycin can be administered in various dosing regimens for different bacterial infections.

- **Acute bacterial sinusitis**: 10 mg/kg once daily for 3 days.

- **Community-acquired pneumonia**: 10 mg/kg as a single dose on Day 1, followed by 5 mg/kg once daily on Days 2 through 5.

- **Pharyngitis/tonsillitis**: 12 mg/kg once daily for 5 days.

Azithromycin for oral suspension can be taken with or without food. The effectiveness of the 3-day or 1-day regimen in pediatric patients with community-acquired pneumonia has not been established. Similarly, the effectiveness of the 5-day or 1-day regimen in pediatric patients with acute bacterial sinusitis has not been established.

---

### Pediatric Dosage Guidelines for Otitis Media, Acute Bacterial Sinusitis, and Community-Acquired Pneumonia

The guidelines are applicable for children aged 6 months and above. Dosages are based on body weight and outlined below:

- **Otitis media and community-acquired pneumonia (5-day regimen)**: Dosing is calculated on 10 mg/kg/day on Day 1 and 5 mg/kg/day on Days 2 to 5.

- **Weight categories**:
	- 5 kg (11 lbs): Day 1: 2.5 mL (½ tsp), Days 2 to 5: 1.25 mL (¼ tsp), Total: 7.5 mL, 150 mg.
	- 10 kg (22 lbs): Day 1: 5 mL (1 tsp), Days 2 to 5: 2.5 mL (½ tsp), Total: 15 mL, 300 mg.
	- 20 kg (44 lbs): Day 1: 5 mL (1 tsp), Days 2 to 5: 2.5 mL (½ tsp), Total: 15 mL, 600 mg.
	- 30 kg (66 lbs): Day 1: 7.5 mL (1½ tsp), Days 2 to 5: 3.75 mL (¾ tsp), Total: 22.5 mL, 900 mg.
	- 40 kg (88 lbs): Day 1: 10 mL (2 tsp), Days 2 to 5: 5 mL (1 tsp), Total: 30 mL, 1200 mg.
	- 50 kg and above (110 lbs and above): Day 1: 12.5 mL (2½ tsp), Days 2 to 5: 6.25 mL (1¼ tsp), Total: 37.5 mL, 1500 mg.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^111Dfgup]. Clinical Infectious Diseases (2012). High credibility.

Regarding the screening and diagnosis for group A streptococcal pharyngitis, specifically in relation to indications for testing asymptomatic contacts, the IDSA 2012 guidelines recommend not to conduct routine testing in asymptomatic household contacts of patients with acute GAS pharyngitis.

---

### Rising ethnic inequalities in acute rheumatic fever and rheumatic heart disease, New Zealand, 2000–2018 [^114WPCAS]. Emerging Infectious Diseases (2021). Low credibility.

Acute rheumatic fever (ARF) is a preventable multisystem inflammatory disease that develops in less than 3% of persons with untreated group A Streptococcus (GAS) pharyngitis. Recently, GAS skin infections have been proposed to cause ARF, either directly or in combination with GAS pharyngitis. The severe sequela of ARF is rheumatic heart disease (RHD) with regurgitation from the mitral valve, aortic valve, or both. RHD is a serious condition that can lead to cardiac failure, stroke, and early death.

ARF and RHD remain major causes of illness and death. In 2015, global prevalence of RHD was approximately 34 million cases, and around 320,000 RHD-associated deaths occurred. During the 20th century, improved living conditions resulted in dramatic declines in ARF. The introduction of antimicrobial drugs in the 1950s and 1960s further reduced the burden of disease and ushered in an effective treatment for GAS pharyngitis. Although now rare in high-income countries, ARF and RHD continue to affect populations in economically disadvantaged areas, and epidemic outbreaks occur in populations that are separated geographically.

The incidence of RHD is highest in Oceania, South Asia, and central sub-Saharan Africa. However, some of the highest reported ARF rates are among indigenous and Pacific Islander populations in Australia and New Zealand. The incidence rate among indigenous children in Australia in the peak age group, 5–14 years, is 245–351 cases per 100,000 population. In New Zealand, ARF almost exclusively affects indigenous Māori and Pacific Islander children living in socioeconomically deprived areas.

---

### Health policy basics: Implementation of the International Classification of Disease, 10th revision [^112re7WE]. Annals of Internal Medicine (2015). Low credibility.

The International Classification of Diseases (ICD) standardizes diagnostic codes into meaningful criteria to enable the storage and retrieval of information regarding patient care. Whereas other countries have been using ICD, 10th Revision (ICD-10), for years, the United States will transition from ICD, Ninth Revision, Clinical Modification (ICD-9-CM), to ICD-10 on 1 October 2015. This transition is one of the largest and most technically challenging changes that the medical community has experienced in the past several decades. This article outlines the implications of moving to ICD-10 and recommends resources to facilitate the transition.

---

### Consensus agreement to rename burning mouth syndrome and improve International Classification of Diseases-11 disease criteria: An international Delphi study [^114HNCE1]. Pain (2021). High credibility.

The International Classification of Diseases (ICD-11) proposes revisions in the nomenclature, disease definition, and diagnostic criteria for "burning mouth syndrome" (BMS). This process could benefit from additional systematically collected expert input. Thus, the purpose of this study was to use the Delphi method to determine whether revisions in nomenclature and alternative names for "BMS" are warranted and to identify areas of consensus among experts for changes to the disease description and proposed diagnostic criteria of "BMS", as described in the ICD-11 (World Health Organization).

From 31 international invited experts, 23 who expressed interest were sent the survey. The study used four iterative surveys, each with a response rate of ≥ 82%. Consensus was predefined as 70% of participants in agreement. Data were summarized using both descriptive statistics and qualitative thematic analysis. Consensus indicated that BMS should not be classified as a syndrome and recommended instead renaming it to "burning mouth disorder".

Consensus included the deletion of two diagnostic criteria:

- **Emotional distress or functional disability**
- **Number of hours symptoms occur per day**:

Additional items that reached consensus clarified the disease definition and proposed more separate diagnostic criteria. This included a list of local and systemic factors to evaluate as potential secondary causes of oral burning. Experts in this study recommended and came to consensus on select revisions to the proposed ICD-11 BMS nomenclature, diagnostic criteria, and disease definition.

---

### Associations between findings of Fusobacterium necrophorum or β-hemolytic streptococci and complications in pharyngotonsillitis — a registry-based study in southern Sweden [^1115hBGA]. Clinical Infectious Diseases (2023). High credibility.

Most pharyngotonsillitis guidelines focus on the identification of group A streptococci (GAS), guided by clinical scores determining whom to test with a rapid antigen detection test. Nevertheless, many patients testing negative with this test are evaluated for group C/G streptococci (GCS/GGS) and Fusobacterium necrophorum, yet their importance remains debated. Our primary aim was to evaluate associations between complications and findings of F. necrophorum, GAS, or GCS/GGS in pharyngotonsillitis.

This was a retrospective, registry-based study of pharyngotonsillitis cases tested for F. necrophorum (polymerase chain reaction) and β-hemolytic streptococci (culture) in the Skåne Region, Sweden, from 2013–2020. Patients with prior complications or antibiotics (within 30 days) were excluded. Data were retrieved from registries and electronic charts. Logistic regression analyses were performed with a dichotomous composite outcome of complications as the primary outcome, based on International Classification of Diseases, Tenth Revision, codes. Cases with negative results (polymerase chain reaction and culture) were set as the reference category. Complications within 30 days were defined as peritonsillar or pharyngeal abscess, otitis, sinusitis, sepsis or septic complications, recurrence of pharyngotonsillitis (after 15–30 days), or hospitalization.

Of 3,700 registered cases, 28% had F. necrophorum, 13% had GCS/GGS, 10% had GAS, and 54% had negative results. The 30-day complication rates were high (20%) for those with F. necrophorum (odds ratio, 1.8; 95% confidence interval).

---

### Defining the emergency general surgery patient population in the era of ICD-10: Evaluating an established crosswalk from ICD-9 to ICD-10 diagnosis codes [^112pqWBE]. The Journal of Trauma and Acute Care Surgery (2023). High credibility.

In 2015, the United States transitioned from the International Classification of Diseases, Ninth Revision (ICD-9), to the International Classification of Diseases, Tenth Revision (ICD-10), coding system. The American Association for the Surgery of Trauma Committee on Severity Assessment and Patient Outcomes had previously established a list of ICD-9 diagnoses to define the field of emergency general surgery (EGS). This study evaluates the general equivalence mapping (GEM) crosswalk to generate an equivalent list of ICD-10-coded EGS diagnoses.

- **Methods**: The GEM was used to generate a list of ICD-10 codes corresponding to the American Association for the Surgery of Trauma ICD-9 EGS diagnosis codes. These individual ICD-9 and ICD-10 codes were aggregated by surgical area and diagnosis groups. The volume of patients admitted with these diagnoses in the National Inpatient Sample in the ICD-9 era (2013–2014) was compared with the ICD-10 volumes to generate observed-to-expected ratios. The crosswalk was manually reviewed to identify the causes of discrepancies between the ICD-9 and ICD-10 lists.

- **Results**: There were 485 ICD-9 codes, across 89 diagnosis categories and 11 surgical areas, which mapped to 1,206 unique ICD-10 codes. A total of 196 (40%) ICD-9 codes have an exact one-to-one match with an ICD-10 code. The median observed-to-expected ratio among the diagnosis groups for a primary diagnosis was 0.98 (interquartile range, 0.82–1.12). There were five key issues identified with the ability of the GEM to crosswalk ICD-9 EGS diagnoses to ICD-10.

---

### Management of adults with acute streptococcal pharyngitis: Minimal value for backup strep testing and overuse of antibiotics [^116miRyS]. Journal of General Internal Medicine (2013). Low credibility.

Rapid antigen detection tests (RADT) are commonly used to guide appropriate antibiotic treatment of group A beta-hemolytic streptococcal (GABHS) pharyngitis. In adults, there is controversy about the need for routine backup testing of negative RADT.

- **Objective**: Estimate the costs and benefits in adults of routine backup testing by DNA Gen-probe of negative RADT (Acceava).

- **Design**: Observational follow-up study.

- **Participants**: All patients aged 18 years and older visiting a Cleveland Clinic generalist physician in 2009 and 2010 with a visit diagnosis of acute pharyngitis (ICD codes 462, 034.0).

- **Main measures**: The patients were identified using the Cleveland Clinic Epic Clarity database. We determined the proportion of false negative RADT, antibiotic prescription patterns, and rate of serious suppurative complications within 30 days of the office visit.

- **Key results**: Of 25,130 patients with acute pharyngitis, 19% had no testing and 81% were tested. Of the 15,555 patients that had a negative RADT and follow-up DNA probe, 6% had a positive DNA probe. Of the 953 patients who had a negative RADT and a positive DNA strep probe, 48% received an antibiotic prescription at the time of the visit and 51% received an antibiotic prescription after an average of 2.3 days. Only one patient with a negative RADT and no follow-up DNA probe developed a peritonsillar abscess. Overall, of the 15,555 DNA probes performed, management was altered in only 3% of the patients at a total cost of $1,757,715. Fifty-six percent received an antibiotic while only 19.5% had a confirmed strep throat.

---

### Global classification and coding of hypersensitivity diseases - An EAACI - WAO survey, strategic paper and review [^116vbNdo]. Allergy (2014). Low credibility.

Hypersensitivity diseases are not adequately coded in the International Coding of Diseases (ICD)-10, resulting in misclassification and leading to low visibility of these conditions and a general inaccuracy of official statistics. To address the inadequacy of ICD-10 concerning allergic and hypersensitivity diseases and to contribute to improvements for the forthcoming revision of ICD, a web-based global survey of healthcare professionals' attitudes toward allergic disorders classification was proposed to the members of the European Academy of Allergy and Clinical Immunology (EAACI) and the World Allergy Organization (WAO). The survey was launched via the internet and circulated for six weeks.

A total of 612 members from 144 countries across all six World Health Organization (WHO) global regions participated in the survey. Although ICD-10 is the most used classification worldwide, the majority of participants did not consider it appropriate in clinical practice. Most respondents indicated that the EAACI-WAO classification is easier and more accurate for daily practice. They emphasized the need for a diagnostic system that is useful for non-allergists and endorsed the possibility of a global, cross-culturally applicable classification system for allergic disorders.

This first and most broadly international survey ever conducted on health professionals' attitudes toward the classification of allergic disorders supports the need to update the classifications of allergic diseases. It can be useful to the WHO in improving the classification system.

---

### Streptococcal pharyngitis: Rapid evidence review [^115dgucv]. American Family Physician (2024). High credibility.

Regarding screening and diagnosis for group A streptococcal pharyngitis, especially concerning the diagnosis, the AAFP 2024 guidelines recommend diagnosing GAS pharyngitis using a validated clinical decision rule. If the patient is determined to be at intermediate or high risk, rapid antigen testing should be obtained.

---

### Pathway to acquire new ICD-10 codes pertinent to new wound care technology [^114SpFAv]. Advances in Wound Care (2018). Low credibility.

New technologies are continually developed for the wound care market. This article provides an overview of the process for obtaining a new or revised ICD-10-Clinical Modification and/or ICD-10-Procedure Coding System code. Manufacturers, providers, and researchers often forget that this process can be lengthy and must be included in product development timelines. An example of the timelines required for implementation of new 2020 ICD-10 codes is provided in the article. Additionally, the article offers insight into the appropriate individuals within a manufacturing organization or consulting firm who may assist with evaluating whether pertinent ICD-10 diagnosis or procedure codes exist within the ICD-10 coding system or whether an application must be submitted for one or more new/revised ICD-10 codes.

---

### Evaluation of international classification of diseases, ninth revision, clinical modification codes for reporting methicillin-resistant Staphylococcus aureus infections at a hospital in Illinois [^116kyhoS]. Infection Control and Hospital Epidemiology (2010). Low credibility.

States, including Illinois, have passed legislation mandating the use of International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for reporting healthcare-associated infections, such as methicillin-resistant Staphylococcus aureus (MRSA).

- **Objective**: To evaluate the sensitivity of ICD-9-CM code combinations for the detection of MRSA infection and to understand implications for reporting.

- **Methods**: We reviewed discharge and microbiology databases from July through August of 2005, 2006, and 2007 for ICD-9-CM codes or microbiology results suggesting MRSA infection at a tertiary care hospital near Chicago, Illinois. Medical records were reviewed to confirm MRSA infection. The time from admission to the first positive MRSA culture result was evaluated to identify hospital-onset MRSA (HO-MRSA) infections. The sensitivity of MRSA code combinations for detecting confirmed MRSA infections was calculated using all codes present in the discharge record (up to 15). The effect of reviewing only 9 diagnosis codes, the number reported to the Centers for Medicare and Medicaid Services, was also evaluated. The sensitivity of the combination of diagnosis codes for the detection of HO-MRSA infections was compared with that for community-onset MRSA (CO-MRSA) infections.

- **Results**: We identified 571 potential MRSA infections using screening criteria; 403 (71%) were confirmed MRSA infections, of which 61 (15%) were classified as HO-MRSA. The sensitivity of MRSA code combinations was 59% for all confirmed MRSA infections when 15 diagnoses were reviewed.

---

### Diagnosis of strep throat in adults: Are clinical criteria really good enough [^113aYefM]. Clinical Infectious Diseases (2002). Low credibility.

The clinical manifestations of group A streptococcal and nonstreptococcal pharyngitis overlap quite broadly. For this reason, the updated Infectious Diseases Society of America practice guideline for group A streptococcal pharyngitis, published in this issue of Clinical Infectious Diseases, recommends laboratory confirmation of the clinical diagnosis by means of either throat culture or a rapid antigen detection test. However, a recently published guideline, developed by a subcommittee of the American College of Physicians-American Society of Internal Medicine (ACP-ASIM) in collaboration with the Centers for Disease Control and Prevention, advocates the use of a clinical algorithm alone, in lieu of microbiologic testing, for confirmation of the diagnosis in adults for whom the suspicion of streptococcal infection is high.

In this discussion, we examine the assumptions of the ACP-ASIM guideline, question whether its recommendations will achieve the stated objective of dramatically decreasing excess antibiotic use, and suggest that its recommendations be confirmed by clinical trials before clinicians abandon long-held teachings regarding the diagnosis and management of group A streptococcal pharyngitis.

---

### Necessity and implications of ICD-10: Facts and fallacies [^11523574]. Pain Physician (2011). Low credibility.

The International Classification of Diseases-10 (ICD-10) is a new system that is expected to be implemented effectively on October 1, 2013. This federally mandated change will affect all payers and providers, and its implementation is projected to surpass both the Health Insurance Portability and Accountability Act (HIPAA) and Y2K in terms of costs and risks. However, the administration aims to implement these changes rapidly, which could pose problems for healthcare in the United States.

In 2003, HIPAA designated ICD-9 as the code set for supporting diagnoses and procedures in electronic administrative transactions. On January 16, 2009, the Department of Health and Human Services (HHS) published a regulation requiring the replacement of ICD-9 with ICD-10 as of October 1, 2013. While ICD-9 and ICD-10 have a similar hierarchical structure, ICD-10 is more complex and incorporates numerous changes. Overall, ICD-10 contains over 141,000 codes, a significant increase of 712% compared to the fewer than 20,000 codes in ICD-9, leading to enormous complexities, confusion, and expense.

Multiple published statistics illustrate that there are approximately 119 instances where a single ICD-9 code can map to more than 100 distinct ICD-10 codes, whereas there are 255 instances where a single ICD-9 code can map to more than 50 ICD-10 codes. Adding to the confusion, there are 3,684 instances in the mapping for diseases where a single ICD-10 code can map to more than one ICD-9 code. Proponents of the new ICD-10 system argue that this granularity should lead to improvements in the quali…

---

### Impact of international classification of diseases, 10th revision, on head and neck surgery [^117Xay2N]. The Laryngoscope (2020). Low credibility.

The study aims to review changes in the number of International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) codes utilized in head and neck surgery services and to assess associated changes in cost and charges of health services.

A retrospective cross-sectional analysis was conducted using the Nationwide Readmissions Database from 2015. The study population included patients admitted for primary head and neck procedures. The focus was on patients discharged in the third quarter (Q3) using the ICD-9-CM coding system compared to those discharged in the fourth quarter (Q4) with the ICD-10-CM coding system.

- **Results**: A total of 11,456 patients were discharged in Q3, while 10,431 patients were discharged in Q4. Comparing the top 90% billed disease codes, the number of ICD-10-CM codes increased by a factor of 1.20. However, when codes were classified by the type of surgery, fewer codes were used in patients who had laryngeal surgeries or tonsillectomy/adenoidectomy, with a reduction by a factor of 0.8. The codes for documenting primary diagnoses in tracheostomy patients increased the most by a factor of 1.42. Controlling for multiple factors affecting health service costs, there were no significant changes in the cost of management per case (Q3: $70,189.00 ± 1,546.39 vs. Q4: $70,502.00 ± 1,560.17, P = 0.68) or hospital charges (Q3: $273,411.00 ± 7,852.78 vs. Q4: $265,996 ± 7,922.77, P = 0.05).

- **Conclusion**: The ICD-10-CM system provides an expansion of codes. Preliminary observations indicate that the utilization of ICD-10-CM codes for head and neck surgery is within expected parameters.

---

### Tonsillitis and tonsilloliths: Diagnosis and management [^111aq2WC]. American Family Physician (2023). High credibility.

Regarding diagnostic investigations for group A streptococcal pharyngitis, more specifically with respect to the rapid antigen detection test, AAFP 2023 guidelines recommend considering obtaining rapid antigen detection testing in patients with a Centor score of ≥ 2.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^116289yc]. Clinical Infectious Diseases (2012). Low credibility.

The guideline is intended for use by healthcare providers who care for adult and pediatric patients with group A streptococcal pharyngitis. The guideline updates the 2002 Infectious Diseases Society of America guideline and discusses diagnosis and management, providing recommendations regarding antibiotic choices and dosing. Penicillin or amoxicillin remain the treatments of choice, and recommendations are made for the penicillin-allergic patient, which now include clindamycin.

---

### Efficacy and safety of rapid tests to guide antibiotic prescriptions for sore throat [^113bY21x]. The Cochrane Database of Systematic Reviews (2020). Low credibility.

Sore throat is a common condition caused by viruses or bacteria and is a leading cause of antibiotic prescription in primary care. The most common bacterial species is group A streptococcus ('strep throat'). Between 50% to 70% of pharyngitis cases are treated with antibiotics, despite the majority of cases being viral in origin. One strategy to reduce antibiotics is to use rapid tests for group A streptococcus to guide antibiotic prescriptions. Rapid tests can be used alone or in combination with a clinical scoring system.

- **Objectives**: To assess the efficacy and safety of strategies based on rapid tests to guide antibiotic prescriptions for sore throat in primary care settings.

- **Search methods**: We searched CENTRAL, MEDLINE, Embase, CINAHL, Web of Science, and LILACS, as well as the trial registries ClinicalTrials.gov and the WHO ICTRP on 5 June 2019.

- **Selection criteria**: We included randomized controlled trials (RCTs) comparing rapid tests with management based on clinical grounds to guide the prescription of antibiotics for people with a sore throat in ambulatory care settings. We included trials that randomized individuals, as well as cluster-RCTs in which individual practitioners (or practices) or emergency departments were randomized.

- **Data collection and analysis**: Two review authors independently extracted data on the primary outcomes (number of participants provided with an antibiotic prescription; number of participants with an antibiotic dispensed) and secondary outcomes (duration of sore throat symptoms; duration of other symptoms; quality of life).

---

### How accurate are International Classification of Diseases-10 diagnosis codes in detecting influenza and pertussis hospitalizations in children [^114tFKsP]. Journal of the Pediatric Infectious Diseases Society (2014). High credibility.

Influenza and pertussis are major causes of pediatric morbidity. We measured the accuracy of their International Classification of Diseases (ICD-10-AM) diagnosis codes using linked population-based laboratory and hospital data in 245,249 children.

- **Specificity and positive predictive value**: Influenza diagnosis codes had high specificity (98.6%) and modest positive predictive value (PPV; 84.1%) and sensitivity (86.1%, 95% CI: 83.4%-88.6%) for a laboratory-confirmed episode. For pertussis diagnosis codes, PPV (86.8%) and specificity (98.9%) were high, but sensitivity was poor (27.8%, 95% CI: 23.5%-32.4%).

- **Variations by demographic factors**: Measures varied according to age, remoteness, Aboriginality, severity, and detection method. Both laboratory and hospitalization data are needed to accurately determine the burden of pediatric influenza and pertussis.

---

### International classification of disease coding for obstructive lung disease: Does it reflect appropriate clinical documentation [^112dTi7a]. Chest (2010). Low credibility.

International Classification of Disease coding is widely used by physicians, hospitals, healthcare payers, and governments to assess the health of populations and as a means of reimbursement for medical care based on diagnosis and severity of illness. The classification system, International Classification of Diseases, 9th edition (ICD-9), will soon be replaced by International Classification of Diseases, 10th edition (ICD-10). When the codes that relate to COPD and asthma are examined, the clinical relevance of the categories in International Classification of Disease coding must be questioned. In the future, a more simplified terminology that is consistent with clinical usage could improve accuracy and ease of coding. At present, however, clinicians should become familiar with the current ICD-9 and future ICD-10 codes so that their descriptions of illnesses in the medical records more accurately reflect coding terminology.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^1121sGnA]. Clinical Infectious Diseases (2012). High credibility.

For primary prevention of rheumatic fever, the 2012 IDSA guidelines recommend obtaining a rapid antigen detection test for GAS pharyngitis in most patients presenting with acute pharyngitis symptoms. This is advised because clinical features alone are insufficient to reliably differentiate between group A streptococcal and viral pharyngitis, except when overt viral features such as rhinorrhea, cough, oral ulcers, and/or hoarseness are present.

---

### Lemierre's syndrome and 2016 American College of Physician guidelines for pharyngitis: No to empiric coverage for bacterial pharyngitis. While no role for routine Fusobacterium PCR, keep suspicion for this pathogen [^116XmpDR]. BMJ Case Reports (2018). Low credibility.

An 18-year-old woman presented to the clinic with acute pharyngitis with 4/4 Centor criteria. A rapid streptococcal antigen test was negative. The patient, allergic to penicillin, was prescribed azithromycin. Ultimately, after five days and without any corticosteroids, she presented to the emergency department with 10/10 chest pain and was admitted to the intensive care unit. CT showed nodular lung disease, and blood cultures on admission grew Fusobacterium, likely Fusobacterium nucleatum. She sustained two cardiac arrests, three tube thoracostomies, acute kidney injury requiring dialysis, and ventilatory failure requiring tracheostomy. After 16 days in the hospital and 18 days in long-term acute care, the patient was discharged home. It is unclear how much of this could have been prevented by prescribing an antimicrobial that had activity against Fusobacterium. When severe pharyngitis occurs, Fusobacterium needs to be considered as an underlying cause. In vitro, macrolides have marginal activity against most anaerobes, such as this pathogen, and should be avoided.

---

### The collective impact of rare diseases in Western Australia: An estimate using a population-based cohort [^111FM788]. Genetics in Medicine (2017). Low credibility.

As a result of the limitations of using Orpha codes in the Australian context, it was necessary to first match Orpha/ICD-10 codes to ICD-10-AM codes and validate the matching process. We have named the outcome of this work the RD resource set. Because the cohort for the study was to be selected from the WA HMDC, we used information from this data collection to assist with the creation of the RD resource set. When developing the resource set, an RD was defined as any noninfectious disease with a prevalence of less than 1 in 2,000 in the general WA population.

We started with 585 RD Orpha codes identified by Orphanet and specifically mapped to one or a set of ICD-10 codes. With guidance from clinical coders, these ICD-10 codes were matched to their equivalent ICD-10-AM codes. A process of "back translation" to Orpha codes was then undertaken to ensure that the ICD-10-AM codes described the same diseases as those captured by the Orpha codes. In some cases, because of discrepancies between the ICD-10 and ICD-10-AM coding systems, the ICD-10-AM code(s) that specifically corresponded to an Orpha code was different from the ICD-10 code provided by Orphanet. Decisions regarding how to assign ICD-10-AM codes for these diseases were made in conjunction with WA medical coding experts.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^117K3WPh]. Clinical Infectious Diseases (2012). High credibility.

Regarding specific circumstances for group A streptococcal pharyngitis, more specifically with respect to asymptomatic household contacts, the IDSA 2012 guidelines recommend not offering routine empiric treatment in asymptomatic household contacts of patients with acute streptococcal pharyngitis.

---

### Guideline for the management of acute sore throat [^113febu4]. Clinical Microbiology and Infection (2012). High credibility.

Regarding the medical management for group A streptococcal pharyngitis, specifically concerning antibiotic therapy, the ESCMID 2012 guidelines recommend administering penicillin V BID or TID for 10 days if antibiotics are indicated.

---

### Notes from the field: Group A streptococcal pharyngitis misdiagnoses at a rural urgent-care clinic — Wyoming, March 2015 [^116c8Ddw]. MMWR. Morbidity and Mortality Weekly Report (2016). High credibility.

Group A streptococcal pharyngitis can be associated with a variety of symptoms and clinical findings, including no history of cough, a positive rapid streptococcal antigen test, increased serum CRP, scarlet fever, and pharyngeal erythema.

Other symptoms may include:

- **Systemic symptoms**: malaise, fever, increased ESR, increased WBC count, headache, vomiting, nausea, abdominal pain
- **Throat and oral symptoms**: pharyngeal exudate, throat pain, dysphagia, odynophagia, tonsillar enlargement, peritonsillar abscess, swollen uvula, tonsillar exudate, palatine petechiae, strawberry tongue
- **Rash and skin symptoms**: sandpaper-like rash, skin rash
- **Diagnostic findings**: positive throat culture for group A streptococci
- **Other symptoms**: cervical lymphadenopathy, upper respiratory tract infection

Children are particularly susceptible to these symptoms.

---

### Updated diagnosis grouping system for pediatric emergency department visits [^1116cGPB]. Pediatric Emergency Care (2023). High credibility.

This study aims to update the Diagnosis Grouping System (DGS) for International Classification of Disease, Tenth Revision (ICD-10) codes for ongoing use. The DGS was developed in 2010 using ICD-9 codes with 21 major groups and 27 subgroups to facilitate research on pediatric patients presenting to emergency departments and required updated classification for more recent ICD codes.

- **Methods**: All emergency department discharges available in the Pediatric Emergency Care Applied Research Network (PECARN) database for 2016 were included to identify ICD-10 codes. These codes were then mapped onto the DGS codes originally derived from ICD-9. We used ICD-10 codes from the PECARN database from 2017 to 2019 to confirm validity.

- **Results**: The DGS was updated with ICD-10 codes based on 2016 PECARN data, and this updated DGS was successfully applied to 6,853,479 (97.3%) of all codes from 2017 to 2019.

- **Discussion**: Using ICD-10 codes from the PECARN Registry, the DGS was updated to reflect ICD-10 codes to facilitate ongoing research.

---

### Rapid diagnostic tests for group A streptococcal pharyngitis: a meta-analysis [^115Zdgvd]. Pediatrics (2014). Low credibility.

Effective management of group A streptococcal (GAS) pharyngitis is hindered by the impracticality of the gold standard diagnostic test: throat culture. Rapid antigen diagnostic tests (RADTs) are a promising alternative, although concerns about their sensitivity and specificity, and variation between test methodologies, have limited their clinical use. The objective of this study was to perform a systematic review with a meta-analysis of the diagnostic accuracy of RADTs for GAS pharyngitis.

- **Methods**: Medline and Embase from 1996 to 2013 were used as data sources. Of 159 identified studies, 48 studies of diagnostic accuracy of GAS RADTs using throat culture on blood agar as a reference standard were selected. Bivariate random-effects regression was used to estimate sensitivity and specificity with 95% confidence intervals (CIs). Additional meta-analyses were performed for pediatric data.

- **Results**: A total of 60 pairs of sensitivity and specificity from 48 studies were included. Overall summary estimates for sensitivity and specificity of RADTs were 0.86 (95% CI 0.83 to 0.88) and 0.96 (95% CI 0.94 to 0.97), respectively, and estimates for pediatric data were similar. Molecular-based RADTs had the best diagnostic accuracy. Considerable variability exists in methodology between studies. There were insufficient studies to allow meta-regression/subgroup analysis within each test type.

- **Conclusions**: RADTs can be used for accurate diagnosis of GAS pharyngitis to streamline management of sore throat in primary care. RADTs may not require culture backup for negative results.

---

### A longitudinal study of Group A streptococcal colonization and pharyngitis in US children [^114ZQdQf]. The Pediatric Infectious Disease Journal (2023). High credibility.

Accurate diagnosis of streptococcal pharyngitis, especially in the context of severe outbreaks of highly pathogenic Group A Streptococcus (GAS), is essential for the prevention of suppurative and nonsuppurative complications of infection, including rheumatic fever and rheumatic heart disease (RHD), as well as preventing the spread of infection. However, signs and symptoms of GAS and viral pharyngitis broadly overlap, rendering diagnosis of GAS pharyngitis on clinical grounds alone difficult. Diagnosis of GAS pharyngitis is further complicated by asymptomatic GAS carriage. Therefore, detection of GAS in the throat, by culture-positive pharyngeal swab or rapid test, is not necessarily pathognomonic of GAS pharyngitis.

Measurements of GAS-specific antibody responses have been employed to evaluate GAS infection, but increases in titer only occur after infection, so they cannot reliably inform acute treatment decisions. Indeed, antistreptolysin O (ASO) titers peak 3–5 weeks after infection, while antideoxyribonuclease B (anti-DNaseB) titers peak 4–6 weeks after infection and may remain elevated for months. Even so, studies have prospectively examined rises in ASO, anti-DNaseB, and antistreptococcal C5a peptidase (anti-SCP) antibody titers associated with episodes of GAS pharyngitis in children, with a suggestion that these measurements might improve diagnostic specificity.

No licensed vaccine is available to prevent GAS-mediated infections. While the low frequency of post-streptococcal sequelae (PSS) would require a large efficacy study, GAS pharyngitis is both common and a precursor to PSS. A GAS pharyngitis vaccine efficacy trial requires an appropriate case definition.

---

### Guideline for the management of acute sore throat [^112rGMcj]. Clinical Microbiology and Infection (2012). High credibility.

Regarding diagnostic investigations for group A streptococcal pharyngitis, specifically concerning inflammatory markers, ESCMID 2012 guidelines recommend not routinely obtaining inflammatory markers (such as ESR, CRP, procalcitonin, anti-DNase B) for the assessment of patients with acute sore throat.

---

### A rare sequela of untreated streptococcus pharyngitis: A case report [^113SgziT]. The Laryngoscope (2025). Low credibility.

A 26-year-old male with no significant past medical history presented to the emergency department (ED) with a one-day history of sore throat. He reported recent exposure to a relative diagnosed with streptococcal pharyngitis. In the ED, a rapid streptococcal Group A nucleic acid amplification test was positive. The patient was prescribed a 10-day course of amoxicillin and was discharged.

One month later, the patient returned to the ED with persisting sore throat, new cough, and hematuria, having only taken one dose of amoxicillin due to pruritus. He was febrile at 100.5 °F with another positive rapid streptococcal test. Urinalysis revealed significant hematuria, pyuria, proteinuria, and positive nitrites. A complete blood count showed an elevated white blood cell count of 20 K/mcL and a slightly elevated creatine phosphokinase. Based on the lab work and clinical picture, he was diagnosed with post-streptococcal glomerulonephritis (PSGN). He received cefdinir for better tolerance and steroids. The patient was discharged with a 10-day course of cefdinir and instructed to follow up at the PCP clinic.

---

### ICD-10: History and context [^114FjhhW]. AJNR. American Journal of Neuroradiology (2016). Low credibility.

In recent months, organized medicine has been consumed by the anticipated transition to the 10th iteration of the International Classification of Disease system. Implementation has come and gone without the disruptive effects predicted by many. Despite the fundamental role the International Classification of Disease system plays in health care delivery and payment policy, few neuroradiologists are familiar with the history of its implementation and implications beyond coding for diseases.

---

### Practice parameter for the diagnosis and management of primary immunodeficiency [^112fR1yL]. The Journal of Allergy and Clinical Immunology (2015). High credibility.

Regarding screening and diagnosis for PFAPA syndrome, specifically with respect to diagnosis, AAAAI/ACAAI 2015 guidelines recommend suspecting periodic fever with aphthous stomatitis, pharyngitis, and adenitis syndrome in young pediatric patients presenting with characteristic clinical features: a prodrome of cardinal features, including fatigue, chills, and oral ulcers on the lips and buccal mucosa, followed by cervical lymphadenopathy, pharyngitis, and high fever.

---

### Caution needed: Molecular diagnosis of pediatric group A streptococcal pharyngitis [^115Dwz6Z]. Journal of the Pediatric Infectious Diseases Society (2018). Low credibility.

Among throat swabs processed in the microbiology laboratory as backup for negative rapid antigen detection test results, we found a significant increase in the proportion that tested positive for group A streptococci after changing from throat culture to a molecular test. For group A streptococcus testing, our hospital laboratory replaced throat cultures with a stand-alone molecular diagnostic test that takes no more than 1 hour to perform. The prevalence of positive laboratory test results increased significantly (P < .0001) after the change to molecular testing, probably because of the extreme sensitivity of the molecular test.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^116AvKmX]. Clinical Infectious Diseases (2012). High credibility.

Regarding diagnostic investigations for group A streptococcal pharyngitis, the 2012 IDSA guidelines specifically recommend against testing for GAS pharyngitis in pediatric or adult patients presenting with acute pharyngitis when clinical and epidemiological features strongly suggest a viral etiology.

---

### Common questions about streptococcal pharyngitis [^1144dknB]. American Family Physician (2016). Low credibility.

Group A beta-hemolytic streptococcal (GABHS) infection causes 15% to 30% of sore throats in children and 5% to 15% in adults, and is more common in the late winter and early spring. The strongest independent predictors of GABHS pharyngitis are patient age of five to 15 years, absence of cough, tender anterior cervical adenopathy, tonsillar exudates, and fever. To diagnose GABHS pharyngitis, a rapid antigen detection test should be ordered in patients with a modified Centor or FeverPAIN score of 2 or 3.

First-line treatment for GABHS pharyngitis includes a 10-day course of penicillin or amoxicillin. Patients allergic to penicillin can be treated with first-generation cephalosporins, clindamycin, or macrolide antibiotics. Nonsteroidal anti-inflammatory drugs are more effective than acetaminophen and placebo for treatment of fever and pain associated with GABHS pharyngitis; medicated throat lozenges used every two hours are also effective. Corticosteroids provide only a small reduction in the duration of symptoms and should not be used routinely.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^117FtXKa]. Clinical Infectious Diseases (2012). High credibility.

Regarding diagnostic investigations for group A streptococcal pharyngitis, specifically concerning throat culture, the IDSA 2012 guidelines recommend obtaining a throat culture in pediatric and adolescent patients if the rapid antigen detection test is negative. Do not obtain throat cultures if the rapid antigen detection test is positive.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^116KcaXp]. Clinical Infectious Diseases (2012). High credibility.

Regarding diagnostic investigations for group A streptococcal pharyngitis, specifically with respect to rapid antigen detection tests, the IDSA 2012 guidelines recommend not testing for GAS pharyngitis in pediatric patients under three years old, as acute rheumatic fever is rare in this age group. The incidence of streptococcal pharyngitis and its classic presentation are also uncommon in young children. However, testing may be considered for selected patients in this age group if risk factors are present, such as having an older sibling with a group A streptococcal infection.

---

### A systematic framework for prioritizing burden of disease data required for vaccine development and implementation: The case for group A streptococcal diseases [^1162N4zg]. Clinical Infectious Diseases (2022). Low credibility.

Policy reviews often assess the impact of vaccination on all-cause disease syndromes, such as all-cause pharyngitis, cellulitis, pneumonia, or sepsis. Due to the mild–moderate symptomatology of Strep A pharyngitis, estimates of disease incidence should include community surveillance data and data from primary care, healthcare clinics, and emergency departments to enable policy decisions within the health sector. While impetigo is generally seen as an issue requiring primary care and also requires community surveillance, a high hospitalization burden in First Nations populations, such as in Australia, has been noted using International Classification of Diseases, 10th Revision (ICD-10), coded skin infections. These data will prove useful for post-licensure population studies evaluating disease trends pre- and post-vaccine introduction. Given increasing global concerns of antimicrobial resistance (AMR), the use of burden of disease data to measure vaccine impact on AMR and estimate reductions in antibiotic use is an additional important requirement for the policy objective.

Cost-of-illness data are essential for financing decisions. However, the drivers of costs differ across acute Strep A endpoints and different socioeconomic settings. For pharyngitis, the associated consequences of increasing AMR and parental productivity losses are likely key drivers for the value of vaccination; the importance of population AMR trends is recognized by WHO's vaccine roadmap. It was recently estimated that 17% of antibiotic prescriptions for pharyngitis among U.S. children could be prevented by a Strep A vaccine.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^111oPecZ]. Clinical Infectious Diseases (2012). High credibility.

Regarding the medical management of group A streptococcal pharyngitis, particularly concerning antibiotic therapy, the IDSA 2012 guidelines recommend considering alternative diagnoses.

---

### Tonsillitis and tonsilloliths: Diagnosis and management [^117P3DY1]. American Family Physician (2023). High credibility.

Regarding classification and risk stratification for group A streptococcal pharyngitis, more specifically with respect to risk assessment, AAFP 2023 guidelines recommend considering the use of a clinical scoring scale, such as the Centor score, in the initial evaluation of pharyngitis and tonsillitis symptoms.

---

### Pseudoepidemic of streptococcal pharyngitis in a hospital pharmacy [^116Anfc9]. American Journal of Infection Control (2001). Low credibility.

Streptococcus pyogenes has recently re-emerged as a significant pathogen causing diseases ranging from pharyngitis to lethal systemic infection. Six hospital pharmacy employees were diagnosed with streptococcal pharyngitis during one week, and antibiotic prophylaxis was requested to halt the outbreak.

- **Objective**: Outbreak investigation.
- **Design**: Review of initial cases and prospective evaluation of the remaining pharmacy employees and the antigen detection test being used.
- **Setting**: Pharmacy and occupational health department of a university hospital.
- **Population**: Sixteen employees of the hospital pharmacy and 19 other employees of the hospital.
- **Results**: The six pharmacy employees who had positive streptococcal antigen detection tests did not have symptoms suggesting streptococcal pharyngitis. Of the 10 remaining pharmacy employees, none had a positive throat culture for S. pyogenes. Specificity of the antigen detection test being used was 53% (95% CI, 30%-75%) in prospective evaluation.
- **Conclusions**: This was believed to represent a pseudoepidemic because none of the six cases had signs or symptoms typical of streptococcal pharyngitis, none of the remaining 10 pharmacy employees had positive throat cultures, and prospective evaluation found low specificity of the antigen detection test. Whereas the use of an accurate test in such a low prevalence setting could have resulted in a higher percentage of results being false-positive, the low specificity of the antigen detection test being used also contributed to the pseudoepidemic.

---

### Azithromycin versus penicillin V for treatment of acute group A streptococcal pharyngitis [^114FzTgx]. The Pediatric Infectious Disease Journal (2002). Low credibility.

- **Objective**: To compare a 3-day azithromycin regimen versus a 10-day penicillin V regimen for the treatment of acute group A streptococcal (GAS) pharyngitis in children and to determine whether viral infection and/or pharyngeal GAS carriage in patients and adult contacts affect clinical and bacteriologic efficacy.

- **Methods**: This multicenter, randomized, comparative, open-label study compared a 3-day, once-daily 10 mg/kg azithromycin oral suspension with a 10-day regimen of 100,000 IU/kg/day penicillin V oral suspension in three divided doses in children with acute GAS pharyngitis. Clinical and bacteriologic efficacy and tolerability of the antibiotics were evaluated, and recurrence of symptoms and infection was monitored for 6 months.

- **Results**: In total, 292 children (age range, 2 to 12 years) received at least one dose of study medication. Clinical success (cure/improvement) with either antibiotic was similar at the end of therapy (Day 14; azithromycin, 95%; penicillin V, 97%) and at Day 28 (azithromycin, 94%; penicillin V, 95%). Bacteriologic eradication was significantly less with azithromycin than with penicillin V at Day 14 (azithromycin, 38%; penicillin V, 81%; P < 0.001) and at Day 28 (azithromycin, 31%; penicillin V, 68%; P < 0.001). There was no associated increase in GAS-related sequelae. The lower incidence of bacteriologic eradication with azithromycin was not the result of possible concomitant viral infections in the patients, GAS carriage in one parent/guardian, or any reduced susceptibility in pretreatment GAS isolates. Both antibiotics were equally well-tolerated.

---

### Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: Nationwide population based cohort and a case crossover study [^112oWydP]. BMJ (2017). Low credibility.

Validation of ICD-10 coding for oral streptococcal infective endocarditis: The study definition of oral streptococcal infective endocarditis, validated using medical records of 130 participants admitted to the hospital with at least one positive blood culture result for oral streptococci, had a sensitivity of 54% and a positive predictive value of 100%.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^115H7z7h]. Clinical Infectious Diseases (2012). High credibility.

Regarding the medical management of group A streptococcal pharyngitis, especially concerning antibiotic therapy, the IDSA 2012 guidelines recommend initiating an appropriate antibiotic, with penicillin or amoxicillin as the drug of choice if there is no allergy to these agents. The antibiotics should be administered at an appropriate dose for a duration sufficient to eradicate the organism from the pharynx, usually over a 10-day period.

---

### ICD-9-CM to ICD-10-CM codes: What? why? how [^117RwFnX]. Advances in Wound Care (2013). Low credibility.

The wound care industry will gain many benefits when International Classification of Diseases (ICD)-10-Clinical Modification (CM) is implemented. One of the main benefits is that the disease classifications will be consistent with clinical practice and medical technology advances. The new classification codes will be very granular, which means the level of specificity will greatly improve. Numerous new codes will represent more specific anatomic sites, etiologies, comorbidities, and complications, improving the ability to demonstrate the severity of illness.

For instance, the new feature of laterality is directly built into the new codes: separate codes will distinguish right, left, and bilateral, where needed. The increased granularity will provide better analysis of disease patterns and outbreaks. Additionally, the United States will finally be using the same diagnosis coding system as the rest of the world.

This article will describe what the ICD-9-CM/ICD-10-CM codes are, why they are so important, and how clinicians and researchers will convert from ICD-9-CM to ICD-10-CM effective October 1, 2014.

---

### Appropriate antibiotic use for acute respiratory tract infection in adults: Advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention [^117EcNvV]. Annals of Internal Medicine (2016). High credibility.

Regarding screening and diagnosis for group A streptococcal pharyngitis, more specifically with respect to indications for testing (symptomatic patients), ACP/CDC 2016 guidelines recommend obtaining a rapid antigen detection test and/or culture for group A Streptococcus in patients with symptoms suggestive of GAS pharyngitis (such as persistent fever, anterior cervical lymphadenopathy, and tonsillar/pharyngeal exudate, or another appropriate combination of symptoms).

---

### Simulation of ICD-9 to ICD-10-CM transition for family medicine: Simple or convoluted [^112d4gSc]. Journal of the American Board of Family Medicine (2016). Low credibility.

The objective of this study was to examine the impact of the transition from the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM), to the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM), on family medicine. It also aimed to identify areas where additional training might be required.

- **Methods**: Family medicine ICD-9-CM codes were obtained from an Illinois Medicaid dataset encompassing 113,000 patient visits and $5.5 million in claims. Using network science, each ICD-9-CM code used by family medicine physicians was evaluated to determine whether the transition was simple or convoluted. A simple transition is defined as one ICD-9-CM code mapping to one or multiple ICD-10-CM codes. A convoluted transition is where the transitions between coding systems are nonreciprocal and complex, with multiple codes for which definitions become intertwined. Three family medicine physicians evaluated the most frequently encountered complex mappings for clinical accuracy.

- **Results**: Of the 1,635 diagnosis codes used by family medicine physicians, 70% were categorized as simple, 27% as convoluted, and 3% had no mapping. For the visits, 75%, 24%, and 1% corresponded with simple, convoluted, and no mapping, respectively. Payment for submitted claims was similarly aligned. Of the frequently encountered convoluted codes, three diagnosis codes were clinically incorrect, but they represent less than 0.1% of the overall diagnosis codes.

- **Conclusions**: The transition to ICD-10-CM is ongoing and presents areas where further investigation and training are needed to ensure accuracy and efficiency.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^113Le879]. Clinical Infectious Diseases (2012). High credibility.

Regarding medical management for group A streptococcal pharyngitis, specifically with respect to analgesics, the IDSA 2012 guidelines recommend considering offering analgesic/antipyretic agents, such as acetaminophen or NSAIDs, as adjunctive therapy for the treatment of moderate-to-severe symptoms or control of high fever associated with GAS pharyngitis.

---

### Patient demographics are associated with testing for group A streptococcal pharyngitis in children [^115TiZPh]. Journal of the Pediatric Infectious Diseases Society (2025). Low credibility.

We conducted a retrospective cohort study of children (ages 3 to 18 years) who had a visit at an outpatient clinic or emergency department affiliated with Vanderbilt University Medical Center, a tertiary care academic medical center located in Nashville, TN. The study period was from January 1, 2023, to December 31, 2023, and included patients with an ICD-10 diagnosis code for ARTI (sinusitis, acute otitis media, viral upper respiratory tract infection, or pharyngitis, including streptococcal pharyngitis) to reduce heterogeneity. Children younger than 3 years were excluded, as GAS testing is rarely indicated in that age group.

All data were extracted from the electronic medical record system (Epic, Verona, WI) and included patient variables such as:

- **Demographics**: age, sex, self-reported race (White, Black, Other, unknown/declined, or missing)
- **Ethnicity**: Hispanic/Latino, Non-Hispanic/Latino, unknown/declined, or missing
- **Language and insurance**: preferred language (English, Non-English, unknown/declined, or missing), insurance status (public, private, self-pay, or missing)
- **Additional details**: zip code, visit diagnosis
- **Testing and prescriptions**: GAS test orders (rapid antigen and PCR) and results, antibiotic prescriptions

Using the patient's zip code, we linked the Centers for Disease Control and Prevention and Agency for Toxic Substances and Disease Registry Social Vulnerability Index (SVI) to each encounter as a surrogate for demographic and socioeconomic factors. These factors included:

- **Socioeconomic factors**: poverty, access to transportation, crowded housing

The SVI was categorized as high, medium-high, low-medium, or low SVI. We also collected information about clinician type (physician).

---

### Zithromax [^112RQmLe]. U.S. Food and Drug Administration (2020). High credibility.

Pharyngitis/tonsillitis: The recommended dose of azithromycin tablets for children with pharyngitis/tonsillitis is 12 mg/kg once daily for 5 days [see Use in Specific Populations (8.4)]. The pediatric dosage guidelines for pharyngitis/tonsillitis (for age 2 years and above) are based on body weight, with dosing calculated at 12 mg/kg/day for 5 days:

- **8 kg (18 lbs)**: 2.5 mL (½ tsp) per day, total of 12.5 mL for the full treatment course, equating to 500 mg in total.
- **17 kg (37 lbs)**: 5 mL (1 tsp) per day, total of 25 mL for the treatment course, equating to 1000 mg in total.
- **25 kg (55 lbs)**: 7.5 mL (1½ tsp) per day, total of 37.5 mL for the treatment course, equating to 1500 mg in total.
- **33 kg (73 lbs)**: 10 mL (2 tsp) per day, total of 50 mL for the treatment course, equating to 2000 mg in total.
- **40 kg (88 lbs)**: 12.5 mL (2½ tsp) per day, total of 62.5 mL for the treatment course, equating to 2500 mg in total.

These guidelines are crucial for ensuring accurate and effective dosing to treat pediatric patients with pharyngitis/tonsillitis.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^116eLGvN]. Clinical infectious diseases (2012). Low credibility.

The guideline is intended for use by healthcare providers who care for adult and pediatric patients with group A streptococcal pharyngitis. The guideline updates the 2002 Infectious Diseases Society of America guideline and discusses diagnosis and management. Recommendations are provided regarding antibiotic choices and dosing. Penicillin or amoxicillin remain the treatments of choice. Recommendations are also made for penicillin-allergic patients, which now include clindamycin.

---

### Different antibiotic treatments for group A streptococcal pharyngitis [^114AaBsW]. The Cochrane Database of Systematic Reviews (2021). High credibility.

Antibiotics provide only modest benefit in treating sore throat, although their effectiveness increases in people with positive throat swabs for group A beta-haemolytic streptococci (GABHS). It is unclear which antibiotic is the best choice if antibiotics are indicated. This is an update of a review first published in 2010, and updated in 2013, 2016, and 2020.

- **Objectives**: To assess the comparative efficacy of different antibiotics in: (a) alleviating symptoms (pain, fever); (b) shortening the duration of the illness; (c) preventing clinical relapse (i.e. recurrence of symptoms after initial resolution); and (d) preventing complications (suppurative complications, acute rheumatic fever, post-streptococcal glomerulonephritis). To assess the evidence on the comparative incidence of adverse effects and the risk-benefit of antibiotic treatment for streptococcal pharyngitis.

- **Search methods**: We searched the following databases up to 3 September 2020: CENTRAL (2020, Issue 8), MEDLINE Ovid (from 1946), Embase Elsevier (from 1974), and Web of Science Thomson Reuters (from 2010). We also searched clinical trial registers on 3 September 2020.

- **Selection criteria**: Randomised, double-blind trials comparing different antibiotics, and reporting at least one of the following: clinical cure, clinical relapse, or complications and/or adverse events.

- **Data collection and analysis**: Two review authors independently screened trials for inclusion and extracted data using standard methodological procedures as recommended by Cochrane. We assessed the risk of bias of included studies.

---

### The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study [^116te4MU]. Annals of Internal Medicine (2015). Low credibility.

Pharyngitis guidelines focus solely on group A β-hemolytic streptococcal infection. European data suggest that in patients aged 15 to 30 years, Fusobacterium necrophorum causes at least 10% of cases of pharyngitis; however, few U.S. data exist.

- **Objective**: To estimate the prevalence of Fusobacterium necrophorum, Mycoplasma pneumoniae, and group A and C/G β-hemolytic streptococcal pharyngitis and to determine whether F. necrophorum pharyngitis clinically resembles group A β-hemolytic streptococcal pharyngitis.

- **Design**: Cross-sectional.

- **Setting**: University student health clinic.

- **Patients**: 312 students aged 15 to 30 years presenting to a student health clinic with an acute sore throat and 180 asymptomatic students.

- **Measurements**: Polymerase chain reaction testing from throat swabs to detect four species of bacteria and signs and symptoms used to calculate the Centor score.

- **Results**: Fusobacterium necrophorum was detected in 20.5% of patients and 9.4% of asymptomatic students. Group A β-hemolytic streptococcus was detected in 10.3% of patients and 1.1% of asymptomatic students. Group C/G β-hemolytic streptococcus was detected in 9.0% of patients and 3.9% of asymptomatic students. Mycoplasma pneumoniae was detected in 1.9% of patients and 0 asymptomatic students. Infection rates with F. necrophorum, group A streptococcus, and group C/G streptococcus increased with higher Centor scores (P < 0.001).

- **Limitations**: The study focused on a limited age group and took place at a single institution. Asymptomatic students, rather than seasonal control participants and a convenience sample, were used.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^117BqgeU]. Clinical Infectious Diseases (2012). High credibility.

Regarding preventative measures for rheumatic fever, specifically with respect to primary prevention, the IDSA 2012 guidelines recommend obtaining a throat culture in pediatric and adolescent patients if the rapid antigen detection test is negative. However, do not obtain throat cultures if the rapid antigen detection test is positive.

---

### ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease [^111czJya]. The American Journal of Gastroenterology (2022). High credibility.

The ACG 2022 guidelines recommend not to obtain routine oropharyngeal or pharyngeal pH monitoring in patients with extraesophageal symptoms of GERD, particularly in those with reflux laryngitis.

---

### Associations between findings of Fusobacterium necrophorum or β-hemolytic streptococci and complications in pharyngotonsillitis - a registry-based study in Southern Sweden [^111jVWCH]. Clinical Infectious Diseases (2023). High credibility.

Most pharyngotonsillitis guidelines focus on the identification of group A streptococci (GAS), guided by clinical scores determining whom to test with a rapid antigen detection test. Nevertheless, many patients testing negative with this test are evaluated for group C/G streptococci (GCS/GGS) and Fusobacterium necrophorum, yet their importance remains debated. Our primary aim was to evaluate associations between complications and findings of F. necrophorum, GAS, or GCS/GGS in pharyngotonsillitis.

- **Methods**: This was a retrospective, registry-based study of pharyngotonsillitis cases tested for F. necrophorum (polymerase chain reaction) and β-hemolytic streptococci (culture) in the Skåne Region, Sweden, in 2013–2020. Patients with prior complications or antibiotics (within 30 days) were excluded. Data were retrieved from registries and electronic charts. Logistic regression analyses were performed with a dichotomous composite outcome of complications as primary outcome, based on International Classification of Diseases, Tenth Revision, codes. Cases with negative results (polymerase chain reaction and culture) were set as reference category. Complications within 30 days were defined as peritonsillar or pharyngeal abscess, otitis, sinusitis, sepsis or septic complications, recurrence of pharyngotonsillitis (after 15–30 days), or hospitalization.

- **Results**: Of 3700 registered cases, 28% had F. necrophorum, 13% had GCS/GGS, 10% had GAS, and 54% had negative results. The 30-day complication rates were high (20%). F. necrophorum (odds ratio, 1.8; 95% confidence interval, 1.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^114kQUTD]. Clinical Infectious Diseases (2012). High credibility.

Regarding medical management for group A streptococcal pharyngitis, more specifically with respect to analgesics, the IDSA 2012 guidelines recommend avoiding the use of aspirin in pediatric patients with GAS pharyngitis.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^113QZa4G]. Clinical Infectious Diseases (2012). High credibility.

Regarding specific circumstances for group A streptococcal pharyngitis, more specifically with respect to chronic group A streptococcal carriers, the IDSA 2012 guidelines recommend not to attempt to identify nor administer antimicrobial therapy in patients with asymptomatic group A streptococcus carriage, as they are unlikely to spread GAS pharyngitis to their close contacts and are at little or no risk for developing suppurative or non-suppurative complications, such as acute rheumatic fever.

---

### Period prevalence of rheumatic heart disease and the need for a centralized patient registry in American Samoa, 2016 to 2018 [^1163khBd]. Journal of the American Heart Association (2021). Low credibility.

Rheumatic heart disease (RHD) is a severe, chronic complication of acute rheumatic fever, triggered by group A streptococcal pharyngitis. Centralized patient registries are recommended for RHD prevention and control, but none exist in American Samoa. Using existing RHD tracking systems, we estimated RHD period prevalence and the proportion of people with RHD documented in the electronic health record.

- **Methods and results**: RHD cases were identified from a centralized electronic health record system, which retrieved clinical encounters with RHD International Classification of Diseases, Tenth Revision, Clinical Modification (ICD‐10‐CM) codes, clinical problem lists referencing RHD, antibiotic prophylaxis administration records, three RHD patient tracking spreadsheets, and an all-cause mortality database. RHD cases had ≥ 1 clinical encounter with RHD ICD‐10‐CM codes, a diagnostic echocardiogram, or RHD as a cause of death, or were included in RHD patient tracking spreadsheets. Period prevalence per 1000 population among children aged < 18 years and adults aged ≥ 18 years from 2016 to 2018, and the proportion of people with RHD with ≥ 1 clinical encounter with an RHD ICD‐10‐CM code were estimated. From 2016 to 2018, RHD was documented in 327 people (57.2% were children aged < 18 years). Overall, RHD period prevalence was 6.3 cases per 1000 and varied by age (10.0 pediatric cases and 4.3 adult cases per 1000). Only 67% of people with RHD had ≥ 1 clinical encounter with an RHD ICD‐10‐CM code.

- **Conclusions**: RHD remains a serious public health problem in American Samoa.

---

### Hostage to history: The duration of antimicrobial treatment for acute streptococcal pharyngitis [^111c6skw]. The Pediatric Infectious Disease Journal (2017). Low credibility.

Oral antimicrobial treatment for acute streptococcal pharyngitis is commonly administered for 10 days. An investigation of journal publications and textbooks from the dawn of the antimicrobial era to the present was conducted to discover the basis for this settled practice. The duration of treatment for acute streptococcal pharyngitis was established half a century ago under conditions significantly different from those currently encountered by the average clinician. The 10-day treatment standard evolved without scientific justification.

There have been no therapeutic trials that have validated the necessity for 10 days of oral antimicrobial treatment, yet the practice persists. Despite the lack of a scientific foundation, the rarity of acute rheumatic fever in developed countries, the high failure rate for streptococcal eradication, and evidence that short-course therapy with a non-penicillin antimicrobial yields equivalent eradication rates are overlooked. The 10-day rule endures due to long clinical usage and the inherent power of the number 10.

Efforts to change this clinical benchmark will likely meet with resistance from practicing physicians.

---

### Impact of mandatory indications for outpatient antibiotic orders on accurate tracking of antibiotic indications [^113Bikp5]. Infection Control and Hospital Epidemiology (2024). High credibility.

Analysis by charted diagnosis: Streptococcal pharyngitis (GAS) was the most frequent charted diagnosis in both pre- and post-indication encounters (34.1% [221/648] pre vs. 30.4% [196/645] post). When comparing congruence in pre-implementation charted diagnosis and ICD10 code, and post-implementation charted diagnosis and mandatory indication, every charted diagnosis category increased in percent congruence except for bronchitis (92.3% pre vs. 88.9% post, difference –3.4%; p = 0.71) and prophylaxis (85.7% pre vs. 57.1% post, difference –28.6%; p = 0.06). Among encounters in which ICD10 code and charted diagnoses were incongruent, the most common charted diagnoses in both the pre- and post-implementation groups were streptococcal pharyngitis (GAS), skin and soft tissue infection (SSTI), urinary tract infection (UTI), and other. Among encounters in which mandatory indication and charted diagnoses were incongruent in the post-implementation group, the most common charted diagnoses were other (14/31; 45%), prophylaxis (6/31; 19%), and sinusitis (4/31, 13%).

- **Figure 1**: Congruent encounters based on charted diagnosis, International Classification of Diseases, Tenth Revision (ICD10) code, and mandatory indication. Congruence of charted diagnosis to ICD10 and mandatory indication among pre- and post-implementation groups is shown. Congruence in the pre-implementation group reflects congruence between ICD10 code and charted diagnosis. Congruence in the post-implementation group reflects congruence between ICD10 code and mandatory antibiotic electronic order indication. GAS, group A.

---

### Guideline for the management of acute sore throat [^1126sEei]. Clinical Microbiology and Infection (2012). High credibility.

Regarding diagnostic investigations for group A streptococcal pharyngitis, specifically in relation to the rapid antigen detection test, the ESCMID 2012 guidelines recommend considering obtaining a rapid antigen detection test in patients with a high likelihood of streptococcal infections (3–4 Centor criteria).

---

### The tragedy of the implementation of ICD-10-CM as ICD-10: Is the cart before the horse or is there a tragic paradox of misinformation and ignorance [^113ub5ko]. Pain Physician (2015). Low credibility.

The forced implementation of ICD-10-CM (International Classification of Diseases, Tenth Revision, Clinical Modification) codes specific to the United States, scheduled for implementation on October 1, 2015, is a major concern for practicing U.S. physicians and a bonanza for the health IT and hospital industry. ICD-10, implemented worldwide, has 14,400 codes, whereas ICD-10-CM, to be implemented in the United States, has 144,000 codes. This implementation is based on a liberal interpretation of the Health Insurance Portability and Accountability Act (HIPAA), which requires an update to ICD-9-CM (International Classification of Diseases, Ninth Revision, Clinical Modification) but says nothing about ICD-10 or beyond.

On June 29, 2015, the Supreme Court ruled that the Environmental Protection Agency unreasonably interpreted the Clean Air Act when it decided to set limits on the emissions of toxic pollutants from power plants without first considering the costs to the industry. This scenario is applicable to the medical industry, with the Centers for Medicare and Medicaid Services (CMS) unreasonably interpreting HIPAA and imposing extensive regulations without considering the cost. In the United States, the ICD-10-CM, with a 10-fold increase in the number of codes, has resulted in a system so complicated that it no longer compares with any other country. Moreover, most WHO members use the ICD-10 system (not ICD-10-CM) only to record mortality in 138 countries.

---

### The global burden of sore throat and group A pharyngitis: A systematic review and meta-analysis [^114hrVQC]. EClinicalMedicine (2022). Low credibility.

Upper respiratory infection by group A Streptococcus (Strep A) and other pathogens can result in a sore throat and clinical diagnosis of pharyngitis or tonsillitis. Strep A sore throat and tonsillitis can progress to more severe infections, such as peritonsillar abscess or invasive infections. Strep A sore throat can also lead to post-infection sequelae, including acute post-streptococcal glomerulonephritis, acute rheumatic fever (ARF), and rheumatic heart disease (RHD). There is limited contemporary data for the global burden of all Strep A related diseases. Based on 2010 estimates, each year RHD caused more than 345,000 deaths. Added to previous estimates that Strep A invasive infection caused more than 163,000 deaths, Strep A was postulated to be the fifth most lethal pathogen in the world. Strep A vaccines could significantly reduce this disease burden. Moreover, the World Health Organization highlights the potential role of Strep A vaccines in reducing antibiotic treatment of presumed Strep A sore throat, which could plausibly lead to reduced levels of antibiotic resistance and associated harms.

Despite the high global burden of Strep A diseases and the existence of several promising candidate vaccines in early development, investment in late-stage development of these candidates has not been forthcoming. Therefore, formal assessment of the value of prospective Strep A vaccines from both a commercial and societal perspective is warranted. The incidence and burden of sore throat and Strep A sore throat are important inputs for assessing the value of Stre.

---

### Variability in the diagnosis and treatment of group A streptococcal pharyngitis by primary care pediatricians [^116BCqma]. Infection Control and Hospital Epidemiology (2014). Low credibility.

To compare practice patterns regarding the diagnosis and management of streptococcal pharyngitis across pediatric primary care practices, a retrospective cohort study was conducted. The setting included all encounters at 25 pediatric primary care practices sharing an electronic health record.

Streptococcal pharyngitis was defined by an International Classification of Diseases, Ninth Revision code for acute pharyngitis, positive laboratory test, antibiotic prescription, and absence of an alternative bacterial infection. Logistic regression models standardizing for patient-level characteristics were used to compare diagnosis, testing, and broad-spectrum antibiotic treatment for children with pharyngitis across practices. Fixed-effects models and likelihood ratio tests were conducted to analyze within-practice variation.

Of 399,793 acute encounters in one calendar year, there were 52,658 diagnoses of acute pharyngitis, including 12,445 diagnoses of streptococcal pharyngitis. After excluding encounters by patients with chronic conditions and standardizing for age, sex, insurance type, and race, there was significant variability across and within practices in the diagnosis and testing for streptococcal pharyngitis. Excluding patients with antibiotic allergies or prior antibiotic use, off-guideline antibiotic prescribing for confirmed group A streptococcal pharyngitis ranged from 1% to 33% across practices (P < .001). At the clinician level, 13 of 25 sites demonstrated significant within-practice variability in off-guideline antibiotic prescribing (P ≤ .05).

---

### Guideline for the management of acute sore throat [^111ncXxk]. Clinical Microbiology and Infection (2012). High credibility.

Regarding the medical management of group A streptococcal pharyngitis, and specifically concerning corticosteroids, the ESCMID 2012 guidelines suggest offering corticosteroids to adult patients with more severe presentations, such as those exhibiting 3–4 Centor criteria.

---

### Identifying patients at lowest risk for streptococcal pharyngitis: A national validation study [^114Zw5eQ]. The Journal of Pediatrics (2020). High credibility.

To determine the prevalence of features of viral illness in a national sample of visits involving children tested for group A Streptococcus pharyngitis, we sought to derive a decision rule to identify patients with features of viral illness who were at low risk of having group A Streptococcus and for whom laboratory testing might be avoided.

- **Study design**: Retrospective validation study using data from electronic health records of patients aged 3–21 years evaluated for sore throat in a national network of retail health clinics (n = 67,127). We determined the prevalence of features of viral illness in patients tested for group A Streptococcus and developed a decision tree algorithm to identify patients with features of viral illness at low risk (< 15%) of having group A Streptococcus.

- **Results**: Overall, 54% of patients had features of viral illness. Among patients with features of viral illness, those without tonsillar exudates who were 11 years or older and either lacked cervical adenopathy or had cervical adenopathy and lacked fever were identified as at low risk for group A Streptococcus according to the decision rule. This group comprised 34% of patients with features of viral illness, or 19% of all patients tested for group A Streptococcus infection.

- **Conclusions**: Our findings provide an objective way to identify patients with features of viral illness who are at low risk of having group A Streptococcus. Improved identification of such patients could enhance appropriate testing and antibiotic prescribing for pharyngitis.

---

### SPL drug information for amoxicillin [^116QqW1R]. U.S. Food and Drug Administration. High credibility.

The dosage of amoxicillin PO for the treatment of group A streptococcal pharyngitis in adults is 1,000 mg PO daily, in 1–2 divided doses for 10 days.

---

### Guideline for the management of acute sore throat [^114hZBTx]. Clinical Microbiology and Infection (2012). High credibility.

Regarding diagnostic investigations for group A streptococcal pharyngitis, specifically concerning throat culture, the ESCMID 2012 guidelines recommend not obtaining a throat culture following a negative rapid antigen test for the diagnosis of group A streptococci in both pediatric and adult patients.

---

### Spatiotemporal trends in Group A streptococcal pharyngitis in the United States [^113Rwx5Q]. Clinical Infectious Diseases (2024). High credibility.

Group A Streptococcus (GAS) causes an estimated 5.2 million outpatient visits for pharyngitis annually in the United States, with incidence peaking in winter. However, the annual spatiotemporal pattern of GAS pharyngitis across the United States is poorly characterized.

- **Methods**: We used outpatient claims data from individuals with private medical insurance between 2010 and 2018 to quantify GAS pharyngitis visit rates across U.S. census regions, subregions, and states. We evaluated seasonal and age-based patterns of geographic spread and the association between school start dates and the summertime upward inflection in GAS visits.

- **Results**: The South had the most visits per person (yearly average, 39.11 visits per 1000 people; 95% confidence interval, 36.21–42.01) and the West had the fewest (yearly average, 17.63 visits per 1000 people; 95% confidence interval, 16.76–18.49). Visits increased earliest in the South and in school-age children. Differences in visits between the South and other regions were most pronounced in the late summer through early winter. Visits peaked earliest in central southern states, in December to January, and latest on the coasts, in March. The onset of the rise in GAS pharyngitis visits correlated with, but preceded, average school start times.

- **Conclusions**: The burden and timing of GAS pharyngitis varied across the continental United States, with the South experiencing the highest overall rates and earliest onset and peak in outpatient visits. Understanding the drivers of these regional differences in GAS pharyngitis will help in identifying effective intervention strategies.

---

### Guideline for the management of acute sore throat [^1144BvYF]. Clinical Microbiology and Infection (2012). High credibility.

Regarding the medical management of group A streptococcal pharyngitis, particularly concerning analgesics, the ESCMID 2012 guidelines recommend offering either ibuprofen or acetaminophen for the relief of acute sore throat symptoms.

---

### Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [^115d74AE]. Clinical Infectious Diseases (2012). High credibility.

Regarding medical management for group A streptococcal pharyngitis, specifically in relation to antibiotic therapy, the IDSA 2012 guidelines recommend initiating any of the following regimens for penicillin-allergic patients:

- **First-generation cephalosporin**: Administer for 10 days if the patient is not anaphylactically sensitive.
- **Clindamycin or clarithromycin**: Administer for 10 days.
- **Azithromycin**: Administer for 5 days.

---

### School-based surveillance for detection of children with acute pharyngitis, rheumatic fever/rheumatic heart disease in Shimla district, Himachal Pradesh, India-a cluster randomized controlled trial [^116vTAeU]. Indian Heart Journal (2018). High credibility.

In India, the incidence of pharyngitis in 2018 was 284 per 100,000 person-years.